[go: up one dir, main page]

MX2019007595A - Compuestos de quelato de manganeso basados en tetra-azabiciclo-macrociclos adecuados como agentes de toma de imagenes mri. - Google Patents

Compuestos de quelato de manganeso basados en tetra-azabiciclo-macrociclos adecuados como agentes de toma de imagenes mri.

Info

Publication number
MX2019007595A
MX2019007595A MX2019007595A MX2019007595A MX2019007595A MX 2019007595 A MX2019007595 A MX 2019007595A MX 2019007595 A MX2019007595 A MX 2019007595A MX 2019007595 A MX2019007595 A MX 2019007595A MX 2019007595 A MX2019007595 A MX 2019007595A
Authority
MX
Mexico
Prior art keywords
azabicycle
macrocycles
tetra
imaging agents
compounds suitable
Prior art date
Application number
MX2019007595A
Other languages
English (en)
Other versions
MX378404B (es
Inventor
Christopher Bales Brian
James Rishel Michael
Richard Meijer Andreas
Jacob THANING Mikkel
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Publication of MX2019007595A publication Critical patent/MX2019007595A/es
Publication of MX378404B publication Critical patent/MX378404B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención proporciona compuestos de la fórmula (I) que representa un poli-aza-macrociclo con brazos laterales de ácido carboxílico que forman complejo con manganeso como el metal del núcleo. Los complejos son adecuados para usarse como agentes de contraste en la toma de imágenes de resonancia magnética (MRI).
MX2019007595A 2016-12-21 2017-12-21 Compuestos de quelato de manganeso basados en tetra-azabiciclo-macrociclos adecuados como agentes de toma de imagenes mri. MX378404B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662437082P 2016-12-21 2016-12-21
PCT/EP2017/084148 WO2018115314A1 (en) 2016-12-21 2017-12-21 Tetraazabicyclo-macrocycle based manganese chelate compounds suitable as mri imaging agents

Publications (2)

Publication Number Publication Date
MX2019007595A true MX2019007595A (es) 2019-09-09
MX378404B MX378404B (es) 2025-03-10

Family

ID=60857088

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019007595A MX378404B (es) 2016-12-21 2017-12-21 Compuestos de quelato de manganeso basados en tetra-azabiciclo-macrociclos adecuados como agentes de toma de imagenes mri.

Country Status (17)

Country Link
US (1) US10730897B2 (es)
EP (1) EP3558394B1 (es)
JP (1) JP7258753B2 (es)
KR (1) KR102550339B1 (es)
CN (1) CN110290815A (es)
AU (1) AU2017382953B2 (es)
BR (1) BR112019012757A2 (es)
CA (1) CA3048104A1 (es)
DK (1) DK3558394T3 (es)
ES (1) ES2813077T3 (es)
HU (1) HUE050402T2 (es)
LT (1) LT3558394T (es)
MX (1) MX378404B (es)
PL (1) PL3558394T3 (es)
RU (1) RU2769699C2 (es)
WO (1) WO2018115314A1 (es)
ZA (1) ZA201904006B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201610738D0 (en) 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds
EP3728168B1 (en) * 2017-12-20 2022-03-30 General Electric Company Anionic chelate compounds
WO2024097160A1 (en) * 2022-10-31 2024-05-10 Yale University Transition metal complexes for mri applications and methods of use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU608759B2 (en) 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
JP2854905B2 (ja) 1988-09-27 1999-02-10 サリユーター・インコーポレイテツド キレート組成物
JPH07502043A (ja) * 1991-12-10 1995-03-02 ザ ダウ ケミカル カンパニー ビシクロポリアザ大環状ホスホン酸、結合体、造影剤及び製造
FR2794744B1 (fr) * 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale
EP1765812B1 (en) 2004-07-02 2009-04-29 Bracco Imaging S.p.A Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
FR2891830B1 (fr) 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
US20090208421A1 (en) 2008-02-19 2009-08-20 Dominique Meyer Process for preparing a pharmaceutical formulation of contrast agents
NO331773B1 (no) 2009-12-18 2012-03-26 Ge Healthcare As Mangankelater, sammensetninger omfattende slike og anvendelse av disse som kontrastmidler for magnettomografi (MR)
KR102231121B1 (ko) * 2013-04-26 2021-03-23 게르브 조영제 제형 및 이와 관련된 제조 방법
GB201610738D0 (en) * 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds

Also Published As

Publication number Publication date
KR102550339B1 (ko) 2023-07-04
JP2020503310A (ja) 2020-01-30
RU2019118365A (ru) 2021-01-22
US20200062791A1 (en) 2020-02-27
AU2017382953A1 (en) 2019-07-04
LT3558394T (lt) 2020-09-10
EP3558394A1 (en) 2019-10-30
BR112019012757A2 (pt) 2019-11-26
MX378404B (es) 2025-03-10
HUE050402T2 (hu) 2020-12-28
WO2018115314A1 (en) 2018-06-28
JP7258753B2 (ja) 2023-04-17
RU2769699C2 (ru) 2022-04-05
CA3048104A1 (en) 2018-06-28
RU2019118365A3 (es) 2021-03-09
AU2017382953B2 (en) 2021-10-21
ES2813077T3 (es) 2021-03-22
EP3558394B1 (en) 2020-06-03
NZ754888A (en) 2025-05-02
DK3558394T3 (da) 2020-08-24
AU2017382953A2 (en) 2019-09-12
KR20190098193A (ko) 2019-08-21
PL3558394T3 (pl) 2020-11-16
CN110290815A (zh) 2019-09-27
ZA201904006B (en) 2022-04-28
US10730897B2 (en) 2020-08-04

Similar Documents

Publication Publication Date Title
PH12017502205A1 (en) New gadolinium chelate compounds for use in magnetic resonance imaging
MX395695B (es) Agentes de contraste diméricos.
MX2018016082A (es) Compuestos quelatos.
IL245039B (en) Metal complexes containing amidoimine ligands
BR112018011541A2 (pt) agentes de contraste
SG11201600956QA (en) Coil assembly for magnetic resonance imaging
EP2941434A4 (en) BIN SPRING CONTRAST ON MANGANE BASIS
EP2981293A4 (en) Metal oxide nanoparticle-based magnetic resonance imaging contrast agent with a central cavity
DK2945957T3 (da) Nye vand-opløselige kompleksdannere og tilsvarende lanthanidkomplekser
EP3624859A4 (en) Compounds for use as iron(iii) mri contrast agents
MX2019007595A (es) Compuestos de quelato de manganeso basados en tetra-azabiciclo-macrociclos adecuados como agentes de toma de imagenes mri.
DE112014004044A5 (de) Rektalspule für Magnet-Resonanz-Tomographie
MX2022002586A (es) Isomeros de quelatos de manganeso.
HUE050765T2 (hu) Etilén-diamin-tetraecetsav-bisz(amid) származékok és Mn(II) ionokkal képzett vonatkozó komplexeik MRI kontrasztanyagként történõ alkalmazásra
RU2012125493A (ru) Металлокомплексы тетра-(4-трет-бутил-5-нитро)фталоцианина
UY35544A (es) Complejos de bis azainositol hafnio para adquisición de imágenes por rayos x
HK40027113A (en) Compounds for use as iron(iii) mri contrast agents
GB202117923D0 (en) Magnetic resonance imaging contrast agents including an imidazole-comprising compound
GB201709715D0 (en) Contrast agents for magnetic resonance imaging
PL411707A1 (pl) Sposób otrzymywania kwasów antrachinono-1-karboksylowych na drodze utleniania